Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net (loss) income	$ (15,141)	$ (3,420)	$ 10,028
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	28,873	31,987	28,842
Amortization of deferred financing fees and debt discount	3,269	3,212	3,290
Deferred financing fees written-off			120
Equity compensation expense	9,268	5,048	3,507
Deferred income taxes	(1,527)	719	8,005
Non-cash impairment charges	958
Disposal of property, plant and equipment	334		53
Changes in operating assets and liabilities, net of effects from purchase of businesses:
Accounts receivable, net	27,631	21,977	(34,800)
Inventories, net	14,927	4,388	(5,345)
Other current assets and noncurrent assets	5,260	(2,376)	(2,053)
Accounts payable	(2,942)	(10,333)	15,512
Accrued expenses	2,379	555	5,047
Other noncurrent liabilities	5,939	120	(2,454)
Net cash provided by operating activities	79,228	51,877	29,752
Cash flows from investing activities:
Purchase of property, plant and equipment	(34,222)	(22,169)	(23,798)
Purchase of intellectual property	(8,662)	(2,500)
Purchase of businesses, net of cash acquired		(1,150)	(1,875)
Net cash used in investing activities	(42,884)	(25,819)	(25,673)
Cash flows from financing activities:
Payments on capital lease obligations	(29)	(26)	(24)
Payments on revolving ABL credit facility	(82,000)	(62,500)	(54,671)
Proceeds from revolving ABL credit facility	70,000	55,500	57,778
Distribution to RBG	(17,276)	(8,385)
Payment of debt issuance costs			(1,282)
Net cash (used in) provided by financing activities	(29,305)	(15,411)	1,801
Effect of exchange rate changes on cash and cash equivalents	(4,193)	700	(399)
Net change in cash and cash equivalents	2,846	11,347	5,481
Cash and cash equivalents, beginning of year	40,852	29,505	24,024
Cash and cash equivalents, end of year	$ 43,698	$ 40,852	$ 29,505